South Korea is enhancing the Saechulbal Fund to reduce debt burdens for small business owners and self-employed individuals.
New incentives for early and diligent repayment, expanded eligibility for payment deferral, and broader regional support are introduced.
These changes are being implemented in 2024 following a policy review by the Financial Services Commission.
The Korea Ministry of SMEs and Startups hosted a Korea-Japan pharma-bio R&D MOU event in Tokyo.
This initiative aims to advance joint research and investment between Korean startups and major Japanese pharmaceutical firms.
The agreement was formalized on June 26, 2024, with ongoing policy support planned.
South Korea is reforming personal delinquent debt management to protect borrowers and support financial recovery.
Key changes include enhanced debt adjustment, stricter oversight of debt sales, and improved statute of limitations practices.
The Financial Services Commission announced these measures at the second Inclusive Finance Grand Transition meeting on February 26, 2024.
South Korea’s Ministry of Land, Infrastructure and Transport has announced the 2030 Mobility Innovation Growth Roadmap.
The roadmap aims to accelerate AI-driven mobility, including autonomous vehicles and urban air mobility, with new regulations and infrastructure.
Key milestones include autonomous vehicle commercialization by 2027 and public UAM services by 2028.
Korea has released the final version of its clinical guidelines for chronic COVID-19 syndrome.
The guidelines introduce a Korean-specific diagnostic scoring system and updated treatment recommendations.
The guidelines are now available on the Korea Disease Control and Prevention Agency portal and in a peer-reviewed journal.
South Korea has announced its first comprehensive plan to improve health and medical access for people with disabilities.
The plan includes integrated disability-friendly hospitals and expansion of health checkup institutions.
Implementation will occur from 2026 to 2030, with annual progress reviews and a mid-term evaluation in 2027.